| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Sun Pharmaceutical Industries Limited (NSE: SUNPHARMA)
SUNPHARMA Technical Analysis
2
| As on 26th Apr 2024 SUNPHARMA SHARE Price closed @ 1506.55 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1244.70 & Sell for SHORT-TERM with Stoploss of 1558.40 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SUNPHARMASHARE Price
| Open | 1531.00 | Change | Price | % |
| High | 1532.00 | 1 Day | -13.60 | -0.89 |
| Low | 1500.05 | 1 Week | -16.25 | -1.07 |
| Close | 1506.55 | 1 Month | -91.55 | -5.73 |
| Volume | 1794350 | 1 Year | 535.30 | 55.11 |
| 52 Week High 1160.80 | 52 Week Low 793.40 | ||||
| SUNPHARMA CURRENT MONTH FUTURE | |||
| Close | 1519.05 | ||
| Contracts Traded | 5526500 | ||
| Open Intrest | 14348600 | ||
| Change In O.I | -2.84 % | ||
| Lot Size | 700 | ||
| SUNPHARMA CURRENT MONTH OPTION | |
| Most Active Call | 1550.00 |
| Most Active put | 1500.00 |
| Highest O.I Buildup Call | 1550.00 |
| Highest O.I Buildup Put | 1450.00 |
| Expiry Date | 2024-05-30 |
| SUNPHARMA ALL MONTHS OPTIONS | |||
| For All SUNPHARMA Options Click Here | |||
NSE INDIA Most Active Stocks
| IDEA | 14.00 | 0.72% |
| YESBANK | 26.15 | 0.77% |
| IRFC | 158.05 | 5.19% |
| GMRINFRA | 90.75 | 6.58% |
| HUDCO | 228.10 | 12.34% |
| MAHABANK | 67.65 | 3.68% |
| SAIL | 168.55 | 2.18% |
| NHPC | 92.55 | 1.65% |
| TATASTEEL | 165.80 | -1.13% |
| IDFCFIRSTB | 84.80 | 1.68% |
NSE INDIA Top Gainers Stocks
| ROSSELLIND | 468.35 | 20.00% |
| MGEL | 23.25 | 19.85% |
| KIRLOSIND | 5232.65 | 12.84% |
| HUDCO | 228.10 | 12.34% |
| DPABHUSHAN | 1133.45 | 10.42% |
| KECL | 130.60 | 10.30% |
| EXCEL | 0.55 | 10.00% |
| ACL | 98.15 | 9.79% |
| ACL | 98.15 | 9.79% |
| ACL | 98.15 | 9.79% |
NSE INDIA Top Losers Stocks
| LTTS | 4778.10 | -7.81% |
| BAJFINANCE | 6731.20 | -7.73% |
| DBSTOCKBRO | 50.90 | -5.91% |
| COMPUSOFT | 33.95 | -5.56% |
| KSB | 4674.75 | -5.21% |
| KSB | 4674.75 | -5.21% |
| KSB | 4674.75 | -5.21% |
| KSB | 4674.75 | -5.21% |
| KSB | 4674.75 | -5.21% |
| KSB | 4674.75 | -5.21% |
| SUNPHARMA Daily Charts |
SUNPHARMA Intraday Charts |
Whats New @ Bazaartrend |
SUNPHARMA Free Analysis |
|
|
SUNPHARMA Important Levels Intraday
| RESISTANCE | 1568.12 |
| RESISTANCE | 1548.37 |
| RESISTANCE | 1536.17 |
| RESISTANCE | 1523.96 |
| SUPPORT | 1489.14 |
| SUPPORT | 1476.93 |
| SUPPORT | 1464.73 |
| SUPPORT | 1444.98 |
SUNPHARMA Target April 2024
| 4th UP Target | 2133.11 |
| 3rd UP Target | 1949.07 |
| 2nd UP Target | 1835.31 |
| 1st UP Target | 1721.55 |
| 1st DOWN Target | 1396.95 |
| 2nd DOWN Target | 1283.19 |
| 3rd DOWN Target | 1169.43 |
| 4th DOWN Target | 985.39 |
SUNPHARMA Weekly Target
| 4th UP Target | 1744.79 |
| 3rd UP Target | 1673.60 |
| 2nd UP Target | 1629.59 |
| 1st UP Target | 1585.58 |
| 1st DOWN Target | 1460.02 |
| 2nd DOWN Target | 1416.01 |
| 3rd DOWN Target | 1372.00 |
| 4th DOWN Target | 1300.81 |
SUNPHARMA Target2024
| 4th UP Target | 2059.44 |
| 3rd UP Target | 1802.88 |
| 2nd UP Target | 1644.29 |
| 1st UP Target | 1485.71 |
| 1st DOWN Target | 1033.19 |
| 2nd DOWN Target | 874.61 |
| 3rd DOWN Target | 716.02 |
| 4th DOWN Target | 459.46 |
Sun Pharmaceutical Industries Limited ( NSE INDIA Symbol : SUNPHARMA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SUNPHARMA Synopsis Technicals View
| 50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
| 100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
| 200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
| MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
| RSI (14) | RSI is 38.14 | Sideways | |
| MFI (14) | MFI is 62.08 | Sideways | |
| CCI (20) | CCI is Below -100 | Over Sold | |
| WILLIAM %R (14) | William %R is -57.96 | Sideways | |
| ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
| PSAR | Stoploss For Long Buy | 403.24 | |
| 10 Day Avg Volume | Traded -6.65 % Less then 10 Day Average Volume | ||
SUNPHARMA Other Details
| Segment | EQ | |
| Market Capital | 1992283652096.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-Specialty & Generic | |
| Offical website | > | |
SUNPHARMA Address
 |
||
SUNPHARMA Latest News
SUNPHARMA Business Profile
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology and ophthalmic, neuro-psychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It also provides APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances, as well as over-the-counter products. Sun Pharmaceutical Industries Limited was founded in 1983 and is based in Mumbai, India. Address: Sun House, Mumbai, India, 400063
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service